Minerva (BEEF3.SA) Azione Prezzo
Minerva Prezzo
Negli ultimi 19 anni Minerva ha aumentato il fatturato del 22,3% all'anno, raggiungendo 54,83 miliardi BRL. L'utile per azione è diminuito del 0,1% all'anno negli ultimi 19 anni. Per Minerva, il margine netto del 1,5% risulta sostanzialmente stabile rispetto al 2,2% di alcuni anni fa. Al prezzo attuale il rendimento da dividendo è pari a circa il 3,75%. Il payout ratio è pari a circa il 24% degli utili. Il dividendo è cresciuto del 1,9% all'anno negli ultimi 17 anni. Il target di prezzo di consenso a 12 mesi per Minerva è 8,16 BRL, circa il 85,9% sopra il prezzo attuale di mercato. Su 17 analisti, 10 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Minerva Prezzo delle azioni
Minerva Azione e analisi azionaria
Domande frequenti sull'azione Minerva
Minerva SA represents values of integrity, innovation, and sustainability in its corporate philosophy. As a leading company in the protein industry, Minerva SA is committed to delivering high-quality products while ensuring ethical practices and responsibility towards the environment. With a focus on providing value-added solutions, Minerva SA constantly strives for excellence in animal welfare, food safety, and customer satisfaction. The company's dedication to continuous improvement and robust management practices has earned Minerva SA a trusted reputation in the global market.
The business model of Minerva SA focuses on the production and distribution of animal protein. As a leading company in the agricultural sector, Minerva specializes in beef, mainly for export purposes. With a vertically integrated production chain, Minerva operates feedlots, slaughterhouses, and processing plants to ensure high-quality standards throughout the entire production process. By prioritizing sustainable and efficient practices, Minerva aims to deliver top-quality products to its customers worldwide, meeting the demand for high-protein food sources. As a global provider of animal protein, Minerva SA plays a significant role in the international meat industry.
Minerva SA is primarily active in the meat processing industry.
The main competitors of Minerva SA in the market include JBS SA, BRF SA, and Marfrig Global Foods.
Minerva SA is a prominent company in the meat processing industry. Founded in 1992, Minerva SA quickly rose to prominence as a major player in the global market. Headquartered in Brazil, the company has expanded its operations to various countries, including Uruguay, Paraguay, Colombia, and Argentina. With a focus on beef exports, Minerva SA has become one of the leading exporters of beef products worldwide. The company continually invests in state-of-the-art facilities and innovative technologies to ensure high-quality standards. With a strong commitment to sustainability and animal welfare, Minerva SA has garnered a solid reputation within the industry.
Minerva SA, a leading company in the meat processing industry, has achieved several significant milestones throughout its history. One notable achievement is the company's expansion into international markets, establishing a strong presence in over 100 countries worldwide. Additionally, Minerva SA has continuously invested in technology, enhancing its production efficiency and product quality. The company's commitment to sustainability is another noteworthy milestone, as it has implemented environmentally friendly practices throughout its operations. Minerva SA has also gained recognition for its focus on animal welfare and responsible sourcing, further solidifying its position as a trusted player in the industry.
Minerva SA is primarily present in Brazil and operates in multiple regions across South America.
Gli analisti fissano attualmente un prezzo obiettivo medio di 8,22 BRL per l’azione Minerva (mediana: 8,16 BRL), pari a +87,3 % rispetto all’ultimo prezzo. Il consenso si basa su 17 giudizi di analisti.
17 analisti valutano attualmente l’azione Minerva: 10 raccomandano l’acquisto, 7 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Minerva ricavi pari a 56,48 miliardi BRL e un utile per azione di 0,30 BRL.
Convertita al tasso di cambio attuale, l’azione Minerva quota 0,78 EUR (4,39 BRL).
L’azione Minerva (BEEF3.SA) è quotata su 2 borse, tra cui: B3 (São Paulo) (BEEF3.SA).
The company Minerva SA is a globally active company specializing in the production and distribution of specialty chemicals, as well as providing services in the field of life science. The company was founded in 1948 and is headquartered in Basel, Switzerland. Minerva SA employs approximately 4,000 employees in 40 branches worldwide and is present in over 90 countries. The core business of the company is the production and sale of specialty chemicals. These include raw materials, intermediates and finished products that are used in various industries such as cosmetics, pharmaceuticals, and the chemical industry. A special focus is placed on the development of organic and inorganic molecules that must meet increasingly complex requirements. Research and development also play an important role in this. With state-of-the-art technologies and machinery, new products and processes are developed to meet the high demands of customers. Another pillar of Minerva SA is the field of life science services. This includes the production and storage of biological materials such as DNA, antibodies, and proteins, as well as conducting clinical studies on behalf of clients. Product analysis and quality control are also part of the offering. In addition to its own products and services, Minerva SA also offers comprehensive service offerings. These include technical support and consulting, training, and customer service in various regions. The company places great value on collaboration with its customers and is there to assist them. Minerva SA places special emphasis on sustainability. The company focuses on continuously improving its products and services to have a positive impact on the environment and society. This includes, for example, the use of renewable energy, waste reduction, and the restoration of former industrial areas. In summary, Minerva SA is an internationally successful company specializing in the production and sale of specialty chemicals and services in the field of life science. With a strong focus on innovation and sustainability, the company aims to be a reliable partner for its customers, supporting them in the development of new products and processes.
Il attesa fatturato di Minerva ammonta a 56,48 miliardi BRL. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Minerva ammonta a 357,44 Mio. BRL. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Minerva è attualmente 14,40. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Minerva.
Il rapporto prezzo/fatturato (P/S) di Minerva è attualmente 0,09. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Minerva.
Il Quality Score AlleAktien per Minerva è 6/10.
L'ISIN di Minerva è BRBEEFACNOR6. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il ticker di Minerva è BEEF3.SA. Con questo simbolo di borsa vengono negoziate le azioni Minerva in borsa.
Azione Minerva
Gruppo di pari di Minerva
Minerva Ticker
Minerva FIGI
Altre metriche e analisi di Minerva in Deep Dive.
La nostra analisi azionaria dell'azione Minerva include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Minerva. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: